PURPOSE: The aims of the present study were to examine whether focal adhesion kinase (FAK) expression is correlated with cervical lymph node metastasis of tongue cancer and to investigate the roles of FAK in the process of cancer cell migration, invasion and anoikis resistance using the human tongue cancer cell line, Tca8113. METHODS: FAK expression was evaluated in 5 normal oral mucosa, 10 premalignant lesions, 80 primary tongue cancers and 41 lymph node metastases using anti-FAK immunohistochemistry. The migration, invasion and anoikis resistance of tongue cancer cells were evaluated using wound healing assays, invasion assays and anoikis induction. The effect of FAK inhibition was evaluated using RNA interference (RNAi). RESULTS: In total, 55 of 80 primary tongue cancers (69%) showed high expression of FAK, and 25 of 80 tumors (31%) and all normal oral mucosa or premalignant lesions showed low expression of FAK. There was a significant correlation between FAK expression and the cervical lymph node metastasis of tongue cancer. Moreover, RNAi-mediated FAK reduction decreased tongue cancer cell migration, invasion and anoikis resistance. CONCLUSIONS: These results suggest that FAK may serve as a marker of cervical lymph node metastasis of tongue cancer and that RNAi targeting FAK could serve as a potential therapeutic for the treatment of tongue cancer.
PURPOSE: The aims of the present study were to examine whether focal adhesion kinase (FAK) expression is correlated with cervical lymph node metastasis of tongue cancer and to investigate the roles of FAK in the process of cancer cell migration, invasion and anoikis resistance using the humantongue cancer cell line, Tca8113. METHODS:FAK expression was evaluated in 5 normal oral mucosa, 10 premalignant lesions, 80 primary tongue cancers and 41 lymph node metastases using anti-FAK immunohistochemistry. The migration, invasion and anoikis resistance of tongue cancer cells were evaluated using wound healing assays, invasion assays and anoikis induction. The effect of FAK inhibition was evaluated using RNA interference (RNAi). RESULTS: In total, 55 of 80 primary tongue cancers (69%) showed high expression of FAK, and 25 of 80 tumors (31%) and all normal oral mucosa or premalignant lesions showed low expression of FAK. There was a significant correlation between FAK expression and the cervical lymph node metastasis of tongue cancer. Moreover, RNAi-mediated FAK reduction decreased tongue cancer cell migration, invasion and anoikis resistance. CONCLUSIONS: These results suggest that FAK may serve as a marker of cervical lymph node metastasis of tongue cancer and that RNAi targeting FAK could serve as a potential therapeutic for the treatment of tongue cancer.
Authors: Galen B Schneider; Zoya Kurago; Rebecca Zaharias; Lynn M Gruman; Michael D Schaller; Mary J C Hendrix Journal: Cancer Date: 2002-12-15 Impact factor: 6.860
Authors: Juan Pablo Rodrigo; Francisco Dominguez; Vanessa Suárez; Marta Canel; Pablo Secades; Maria Dolores Chiara Journal: Arch Otolaryngol Head Neck Surg Date: 2007-02
Authors: Marta Canel; Pablo Secades; Juan-Pablo Rodrigo; Rubén Cabanillas; Agustín Herrero; Carlos Suarez; María-Dolores Chiara Journal: Clin Cancer Res Date: 2006-06-01 Impact factor: 12.531
Authors: S E Theocharis; G P Kouraklis; J D Kakisis; H G Kanelli; F E Apostolakou; G M Karatzas; A S Koutselinis Journal: Eur J Surg Oncol Date: 2003-09 Impact factor: 4.424
Authors: Carla Cicchini; Ilaria Laudadio; Franca Citarella; Marco Corazzari; Corinna Steindler; Alice Conigliaro; Antonio Fantoni; Laura Amicone; Marco Tripodi Journal: Exp Cell Res Date: 2007-09-18 Impact factor: 3.905
Authors: Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher Journal: Pharmacol Res Date: 2020-02-13 Impact factor: 7.658